PubMed=8512807; DOI=10.1038/bjc.1993.229; PMCID=PMC1968525
Nouri A.M.E., Hussain R.F., Dos Santos A.V.L., Mansouri M., Oliver R.T.D.
Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing.
Br. J. Cancer 67:1223-1228(1993)

PubMed=7534804; DOI=10.1016/0022-1759(94)00299-C
Nouri A.M.E., Mansouri M., Hussain R.F., Dos Santos A.V.L., Oliver R.T.D.
Super-sensitive epithelial cell line and colorimetric assay to replace the conventional K562 target and chromium release assay for assessment of non-MHC-restricted cytotoxicity.
J. Immunol. Methods 180:63-68(1995)

PubMed=10948322; DOI=10.3892/or.7.5.959
Nouri A.M.E., Symes M.O.
Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
Oncol. Rep. 7:959-964(2000)

PubMed=12127398; DOI=10.1016/S0165-4608(01)00648-3
Strefford J.C., Lillington D.M., Steggall M., Lane T.M., Nouri A.M.E., Young B.D., Oliver R.T.D.
Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.
Cancer Genet. Cytogenet. 135:139-146(2002)

PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)